DE69833751D1 - IN POSITION 5 UND 6 MODIFIZIERTE GONADOTROPIN FREISETZENDES HORMON (GnRH)-ANTAGONISTEN - Google Patents

IN POSITION 5 UND 6 MODIFIZIERTE GONADOTROPIN FREISETZENDES HORMON (GnRH)-ANTAGONISTEN

Info

Publication number
DE69833751D1
DE69833751D1 DE69833751T DE69833751T DE69833751D1 DE 69833751 D1 DE69833751 D1 DE 69833751D1 DE 69833751 T DE69833751 T DE 69833751T DE 69833751 T DE69833751 T DE 69833751T DE 69833751 D1 DE69833751 D1 DE 69833751D1
Authority
DE
Germany
Prior art keywords
gonadotropine
hormon
gnrh
antagonists
modified
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69833751T
Other languages
English (en)
Other versions
DE69833751T2 (de
Inventor
Guangcheng Jiang
Graeme Semple
Jean E F Rivier
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ferring BV
Original Assignee
Ferring BV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=25273352&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE69833751(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Ferring BV filed Critical Ferring BV
Publication of DE69833751D1 publication Critical patent/DE69833751D1/de
Application granted granted Critical
Publication of DE69833751T2 publication Critical patent/DE69833751T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/23—Luteinising hormone-releasing hormone [LHRH]; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A61K38/09—Luteinising hormone-releasing hormone [LHRH], i.e. Gonadotropin-releasing hormone [GnRH]; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/02—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/11—Gonadotropin; related peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Endocrinology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Reproductive Health (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Diabetes (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Gynecology & Obstetrics (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE69833751T 1997-04-11 1998-04-13 IN POSITION 5 UND 6 MODIFIZIERTE GONADOTROPIN FREISETZENDES HORMON (GnRH)-ANTAGONISTEN Expired - Lifetime DE69833751T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/837,042 US5925730A (en) 1997-04-11 1997-04-11 GnRH antagonists
US837042 1997-04-11
PCT/US1998/007438 WO1998046634A1 (en) 1997-04-11 1998-04-13 GnRH ANTAGONISTS BEING MODIFIED IN POSITIONS 5 AND 6

Publications (2)

Publication Number Publication Date
DE69833751D1 true DE69833751D1 (de) 2006-05-04
DE69833751T2 DE69833751T2 (de) 2006-11-09

Family

ID=25273352

Family Applications (2)

Application Number Title Priority Date Filing Date
DE200912000033 Active DE122009000033I2 (de) 1997-04-11 1998-04-13 In position 5 und 6 modifizierte gonadotropin freisetzendes hormon (GnRH)-antagonisten.
DE69833751T Expired - Lifetime DE69833751T2 (de) 1997-04-11 1998-04-13 IN POSITION 5 UND 6 MODIFIZIERTE GONADOTROPIN FREISETZENDES HORMON (GnRH)-ANTAGONISTEN

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DE200912000033 Active DE122009000033I2 (de) 1997-04-11 1998-04-13 In position 5 und 6 modifizierte gonadotropin freisetzendes hormon (GnRH)-antagonisten.

Country Status (37)

Country Link
US (2) US5925730A (de)
EP (1) EP1003774B1 (de)
JP (2) JP4249806B2 (de)
KR (1) KR100519421B1 (de)
CN (1) CN1230442C (de)
AR (1) AR011217A1 (de)
AT (1) ATE319736T1 (de)
AU (1) AU728642B2 (de)
BR (1) BR9808523B1 (de)
CA (1) CA2286190C (de)
CY (2) CY1108063T1 (de)
CZ (1) CZ299097B6 (de)
DE (2) DE122009000033I2 (de)
DK (1) DK1003774T3 (de)
EE (1) EE03974B1 (de)
ES (1) ES2260833T3 (de)
FR (1) FR09C0028I2 (de)
HK (1) HK1025104A1 (de)
HR (1) HRP980197B1 (de)
HU (1) HU224836B1 (de)
IL (1) IL132303A0 (de)
LU (1) LU91585I2 (de)
MY (1) MY114811A (de)
NL (1) NL300395I2 (de)
NO (2) NO324991B1 (de)
NZ (1) NZ500142A (de)
PL (1) PL194509B1 (de)
PT (1) PT1003774E (de)
RU (1) RU2199549C2 (de)
SI (1) SI1003774T1 (de)
SK (1) SK285381B6 (de)
TR (1) TR199902956T2 (de)
TW (1) TW505658B (de)
UA (1) UA58547C2 (de)
UY (1) UY24958A1 (de)
WO (1) WO1998046634A1 (de)
ZA (1) ZA983062B (de)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6828415B2 (en) * 1993-02-19 2004-12-07 Zentaris Gmbh Oligopeptide lyophilisate, their preparation and use
US5925730A (en) * 1997-04-11 1999-07-20 Ferring Bv GnRH antagonists
US5977302A (en) * 1997-11-20 1999-11-02 Ortho-Mcneil Pharmaceutical, Inc. Liquid phase process for the preparation of GnRH peptides
US20070148228A1 (en) * 1999-02-22 2007-06-28 Merrion Research I Limited Solid oral dosage form containing an enhancer
US7658938B2 (en) 1999-02-22 2010-02-09 Merrion Reasearch III Limited Solid oral dosage form containing an enhancer
US8119159B2 (en) * 1999-02-22 2012-02-21 Merrion Research Iii Limited Solid oral dosage form containing an enhancer
GB0117057D0 (en) * 2001-07-12 2001-09-05 Ferring Bv Pharmaceutical composition
IL147138A0 (en) * 2001-12-17 2002-08-14 Yeda Res & Dev Methods of and pharmaceutical compositions for modulating cell adhesion, migration and extravasation
DE20321887U1 (de) 2003-11-10 2012-01-20 Allergan, Inc. Arzneimittel umfassend niedrige Dosierungen von Desmopressin
CN1878563A (zh) 2003-11-10 2006-12-13 西摩·H·费恩 包含低剂量去氨加压素的药物组合物
CN101037472B (zh) * 2006-03-14 2013-03-27 中国人民解放军军事医学科学院毒物药物研究所 具有低组胺释放作用的促黄体生成素释放激素拮抗剂
KR101191322B1 (ko) * 2006-04-07 2012-10-16 메리온 리서치 Ⅲ 리미티드 증진제를 함유하는 고형 경구용 투여 제형
TWI442932B (zh) 2008-02-11 2014-07-01 Ferring Int Ct Sa 以ＧｎＲＨ拮抗劑治療攝護腺癌的方法
TW200950799A (en) * 2008-05-07 2009-12-16 Merrion Res Iii Ltd Compositions of GnRH related compounds and processes of preparation
US20100215743A1 (en) * 2009-02-25 2010-08-26 Leonard Thomas W Composition and drug delivery of bisphosphonates
DK2421887T3 (en) * 2009-04-24 2015-07-27 Polypeptide Laboratories As A process for the preparation of degarelix
CN105663059A (zh) * 2009-05-01 2016-06-15 辉凌公司 用于治疗前列腺癌的组合物
TW201043221A (en) * 2009-05-06 2010-12-16 Ferring Int Ct Sa Kit and method for preparation of a Degarelix solution
US20110039787A1 (en) * 2009-07-06 2011-02-17 Ferring International Center S.A. Compositions, kits and methods for treating benign prostate hyperplasia
WO2011066386A1 (en) 2009-11-25 2011-06-03 Novetide, Ltd. Process for production of degarelix
US20110182985A1 (en) * 2010-01-28 2011-07-28 Coughlan David C Solid Pharmaceutical Composition with Enhancers and Methods of Preparing thereof
US9089484B2 (en) * 2010-03-26 2015-07-28 Merrion Research Iii Limited Pharmaceutical compositions of selective factor Xa inhibitors for oral administration
EP2447276A1 (de) * 2010-10-27 2012-05-02 Ferring B.V. Verfahren zur Herstellung von Degarelix und seinen Zwischenprodukten
RS55457B1 (sr) 2010-10-27 2017-04-28 Ferring Bv Postupak za proizvodnju degareliksa i njegovih intermedijara
WO2012088397A2 (en) 2010-12-22 2012-06-28 The Salk Institute For Biological Studies Cyclic crf antagonist peptides
JP2014501784A (ja) 2011-01-07 2014-01-23 メリオン・リサーチ・Ｉｉｉ・リミテッド 経口投与用の鉄の医薬組成物
JO3755B1 (ar) 2011-01-26 2021-01-31 Ferring Bv تركيبات تستوستيرون
WO2013104745A1 (en) 2012-01-13 2013-07-18 Ferring Bv Pharmaceutical composition
RU2657444C2 (ru) 2012-06-01 2018-06-13 Ферринг Б.В. Получение дегареликса
JP7211704B2 (ja) 2015-01-29 2023-01-24 ノヴォ ノルディスク アー／エス Ｇｌｐ－１アゴニスト及び腸溶コーティングを含む錠剤
US11168114B2 (en) 2015-12-17 2021-11-09 Fresenius Kabi iPSUM S.r.l Process for the manufacture of degarelix and its intermediates
CN107778355B (zh) * 2016-08-25 2021-04-20 成都圣诺生物制药有限公司 一种合成西曲瑞克的方法
WO2019110688A1 (en) 2017-12-05 2019-06-13 Ferring B.V. A composition comprising degarelix for use in the treatment of breast cancer
EP4004001A4 (de) 2019-07-29 2023-08-30 Sunshine Lake Pharma Co., Ltd. Substituierte pyrimidindionverbindungen und verwendungen davon
US11332495B2 (en) 2019-09-21 2022-05-17 RK Pharma Solutions LLC Process for the preparation of Degarelix acetate and Degarelix acetate-mannitol premix
CN114456236A (zh) * 2020-11-09 2022-05-10 深圳市健翔生物制药有限公司 一种地加瑞克乙酰化杂质的制备方法
WO2023072284A1 (zh) 2021-11-01 2023-05-04 山东绿叶制药有限公司 促性腺素释放激素拮抗剂及其制备方法和应用

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4547370A (en) * 1983-11-29 1985-10-15 The Salk Institute For Biological Studies GnRH Antagonists
US4508921A (en) * 1984-06-28 1985-04-02 Merck & Co., Inc. Process for preparation of alpha-alkyl amino acids
US4866160A (en) * 1985-04-09 1989-09-12 The Administrators Of The Tulane Educational Fund Therapeutic decapeptides
US5073624A (en) * 1985-04-09 1991-12-17 Administrators Of The Tulane Educational Fund Therapeutic decapeptides
US4800191A (en) * 1987-07-17 1989-01-24 Schally Andrew Victor LHRH antagonists
US4935491A (en) * 1987-08-24 1990-06-19 Board Of Regents, The University Of Texas System Effective antagonists of the luteinizing hormone releasing hormone which release negligible histamine
US5171835A (en) * 1988-10-21 1992-12-15 The Administrators Of The Tulane Educational Fund LHRH antagonists
US5296468A (en) * 1989-10-30 1994-03-22 The Salk Institute For Biological Studies GnRH analogs
ES2052488T3 (es) * 1991-04-25 1997-01-01 Romano Deghenghi Peptidos antagonistas de la hormona de liberacion de la hormona luteinizante.
ES2164096T3 (es) * 1992-12-18 2002-02-16 Abbott Lab Antagonistas de lhrh que comprenden restos de aminoacilo modificados en posicion 5 y 6.
IL108509A0 (en) * 1993-02-22 1994-05-30 Salk Inst For Biological Studi GnRH antagonist peptides
US5506207A (en) * 1994-03-18 1996-04-09 The Salk Institute For Biological Studies GNRH antagonists XIII
US5843901A (en) * 1995-06-07 1998-12-01 Advanced Research & Technology Institute LHRH antagonist peptides
US5925730A (en) * 1997-04-11 1999-07-20 Ferring Bv GnRH antagonists

Also Published As

Publication number Publication date
FR09C0028I2 (fr) 2010-06-11
JP2005120101A (ja) 2005-05-12
NO2009016I2 (no) 2014-08-25
NO324991B1 (no) 2008-01-14
PT1003774E (pt) 2006-05-31
EE9900479A (et) 2000-06-15
AU6969898A (en) 1998-11-11
JP4249806B2 (ja) 2009-04-08
HUP0002704A3 (en) 2003-08-28
US6214798B1 (en) 2001-04-10
NZ500142A (en) 2001-10-26
SI1003774T1 (sl) 2006-08-31
AR011217A1 (es) 2000-08-02
DE122009000033I2 (de) 2011-07-21
US5925730A (en) 1999-07-20
CN1259959A (zh) 2000-07-12
DE122009000033I1 (de) 2009-09-17
TR199902956T2 (xx) 2000-08-21
CY2009008I1 (el) 2012-01-25
KR100519421B1 (ko) 2005-10-06
SK285381B6 (sk) 2006-12-07
CZ358699A3 (cs) 2000-06-14
PL194509B1 (pl) 2007-06-29
NL300395I2 (nl) 2010-01-04
CN1230442C (zh) 2005-12-07
HU224836B1 (en) 2006-03-28
NO994906D0 (no) 1999-10-08
HRP980197A2 (en) 1999-02-28
UA58547C2 (uk) 2003-08-15
KR20010006233A (ko) 2001-01-26
HRP980197B1 (en) 2002-08-31
LU91585I2 (fr) 2009-09-17
BR9808523B1 (pt) 2010-02-09
MY114811A (en) 2003-01-31
BR9808523A (pt) 2000-05-23
IL132303A0 (en) 2001-03-19
ZA983062B (en) 1998-10-20
AU728642B2 (en) 2001-01-11
NO994906L (no) 1999-12-13
CY2009008I2 (el) 2012-01-25
JP3645255B1 (ja) 2005-05-11
RU2199549C2 (ru) 2003-02-27
NL300395I1 (nl) 2009-09-01
CY1108063T1 (el) 2012-01-25
CA2286190A1 (en) 1998-10-22
UY24958A1 (es) 2001-03-16
EP1003774A1 (de) 2000-05-31
TW505658B (en) 2002-10-11
CZ299097B6 (cs) 2008-04-23
HUP0002704A2 (hu) 2000-12-28
ATE319736T1 (de) 2006-03-15
DE69833751T2 (de) 2006-11-09
ES2260833T3 (es) 2006-11-01
FR09C0028I1 (de) 2009-09-25
NO2009016I1 (no) 2009-08-10
JP2001523229A (ja) 2001-11-20
DK1003774T3 (da) 2006-07-03
SK139699A3 (en) 2000-11-07
HK1025104A1 (en) 2000-11-03
WO1998046634A1 (en) 1998-10-22
CA2286190C (en) 2007-01-09
EP1003774B1 (de) 2006-03-08
EE03974B1 (et) 2003-02-17
PL336213A1 (en) 2000-06-05

Similar Documents

Publication Publication Date Title
DE69833751D1 (de) IN POSITION 5 UND 6 MODIFIZIERTE GONADOTROPIN FREISETZENDES HORMON (GnRH)-ANTAGONISTEN
DE69701119D1 (de) Chipantenne und Antennenvorrichtung
HUP0102535A3 (en) Cd19xcd3 specific polypeptides and uses thereof
DE69830883D1 (de) Halbleiterbauelement und mit diesem Bauelement bestückte Leiterplatte
LV11460A (lv) Estrogenu agonisti un antagonisti
DE69832359D1 (de) Halbleitervorrichtung -anordnung und -schaltungen
DE69832657D1 (de) Empfangseinrichtungen und Empfangsverfahren
DE69835254D1 (de) Empfangseinrichtungen und Empfangsverfahren
IL141586A0 (en) Cyclic prosaposin-derived peptide and uses thereof
DE69903961T2 (de) Muscarinagonisten und antagonisten
DE69808228D1 (de) Integrierte sammelleitung und entlüftungsventil
PT811593E (pt) Agentes insecticidas e acaricidas 1,4-diaril-2-fluor-2-buteno
DE69816241D1 (de) Aktivierte peptide und konjugate
EP1302770A4 (de) Mit partikeln markierte proteine und immunochromatographische anwendung selbiger
GB9701374D0 (en) Purinergic agonists and antagonists
DE29722200U1 (de) Größen- und formveränderbares Bekleidungsstück
DE69839715D1 (de) Analoges FIFO-Speichergerät
KR970014268U (ko) 유니언일체형 볼밸브
DE29816577U1 (de) Wiege- und Sortiervorrichtung
EP1311282A4 (de) Hochaffine integrinpolypeptide und deren verwendung
GB9828036D0 (en) Oligopeptides and their use
IL154108A0 (en) High affinity integrin polypeptides and uses thereof
IT246531Y1 (it) Dispositivo di controllo dell'accesso e terminale d'accesso
BR1100986A (pt) Conjugados, e, hirudina-muteìna